PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Sep-2023 NEUPATH SUCCESSFULLY COMPLETES SALE OF CORPORATE-OWNED MEDICAL FACILITY Businesswire
05-Sep-2023 Anaesthesia Machines Market Poised for 5.7% CAGR Growth Beyond US$ 2.4 Billion in 2027 | FMI Insights MARKITWIRED
05-Sep-2023 Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19 Businesswire
05-Sep-2023 Safe & Green Holdings Corp. Announces the Appointment of Jill Anderson to the Company’s Board of Directors Businesswire
05-Sep-2023 IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023 Businesswire
05-Sep-2023 Coagulation Analysers Market to Expand Significantly, Predicted Worth US$ 2.1 Billion by 2032 with 6.8% CAGR | FMI Insights MARKITWIRED
05-Sep-2023 Procaps Group Reports Second Quarter 2023 Results Businesswire
05-Sep-2023 Revolutionizing Glaucoma Management: Emerging Therapies Projected to Drive Global Market to 2032 - ResearchAndMarkets.com Businesswire
05-Sep-2023 Epigenomics AG: Pareto and Warburg publish analyst research reports Epigenomics AG
05-Sep-2023 Revvity Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries Businesswire
05-Sep-2023 Armis Appoints Alex Mosher to Chief Revenue Officer Businesswire
05-Sep-2023 Applied Industrial Technologies Acquires Bearing Distributors and Cangro Industries Businesswire
05-Sep-2023 Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics Businesswire
05-Sep-2023 Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives Businesswire
05-Sep-2023 OmniAb to Participate in Two Investor Conferences in September Businesswire
05-Sep-2023 PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant to use AI platforms to design new drugs for mental health disorders Businesswire
05-Sep-2023 Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer Businesswire
05-Sep-2023 IPA Announces Board Refreshment Businesswire
05-Sep-2023 Cybin Announces Grant of U.S. Patent Covering Deuterated Tryptamines Businesswire
05-Sep-2023 Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies Businesswire